RT Journal Article
SR Electronic
T1 COVID-19 and the kidney
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 619
OP 631
DO 10.3949/ccjm.87a.20072
VO 87
IS 10
A1 Hassanein, Mohamed
A1 Radhakrishnan, Yeshwanter
A1 Sedor, John
A1 Vachharajani, Tushar
A1 Vachharajani, Vidula T.
A1 Augustine, Joshua
A1 Demirjian, Sevag
A1 Thomas, George
YR 2020
UL http://www.ccjm.org/content/87/10/619.abstract
AB COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets of SARS-CoV-2 infection, since the virus enters cells through the angiotensin-converting enzyme 2 receptor, which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is evolving rapidly. This article discusses the pathogenesis of acute kidney injury (AKI) in COVID-19, its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients with end-stage kidney disease on dialysis, and kidney transplant recipients.